Showing results (101-110 of 183) with videos related to
Sort By:
Pageof 19
American Journal of Hematology|February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centersYasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.Cell Reports|June 25, 2020
Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic CellsZhigang Cai, Fabiola Aguilera, Baskar Ramdas, et al.Mitochondrion|December 15, 2010
Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial functionMary A Selak, Elise Lyver, Elizabeth Micklow, et al.Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.Haematologica|March 13, 2025
Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trialRichard F Schlenk, Pau Montesinos, Hee-Je Kim, et al.Blood|January 26, 2022
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trialAlexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic LeukemiaNoelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AMLKeith W Pratz, Mohamad Cherry, Jessica K Altman, et al.The Journal of Biological Chemistry|July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolismMargret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.Plos One|April 7, 2016
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E Sloan, Marlise R Luskin, Anne M Boccuti, et al.Pageof 19